Welcome to our dedicated page for Acm Research SEC filings (Ticker: ACMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ACM Research, Inc. (ACMR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. ACM is a NASDAQ‑listed supplier of wafer and panel processing solutions for semiconductor and advanced packaging applications, and its filings offer detailed insight into its operations, financial performance and corporate structure.
Among the key documents, investors can review Form 10‑K annual reports and Form 10‑Q quarterly reports, which describe ACM’s semiconductor process equipment business spanning cleaning, electroplating, stress‑free polishing, vertical furnace processes, track systems, PECVD, and wafer‑ and panel‑level packaging tools. These reports typically discuss revenue drivers, contributions from its principal operating subsidiary ACM Research (Shanghai), Inc., and risk factors relevant to its markets and listings.
Frequent Form 8‑K current reports from ACM detail material events such as quarterly financial results, preliminary revenue and shipment ranges, backlog disclosures from ACM Shanghai, and capital raising activities at ACM Shanghai under STAR Market regulations. These filings often incorporate the full text of related press releases, providing official context for operating and financing updates.
Users can also locate Form 4 insider transaction reports, which disclose purchases and sales of ACMR equity by directors, officers and other insiders, as well as proxy materials that address governance matters and executive compensation. Stock Titan’s interface surfaces these filings with AI‑powered summaries that explain the significance of long and technical documents, highlight key changes across reporting periods, and make it easier to interpret complex sections of 10‑K, 10‑Q and 8‑K reports.
With real‑time updates from EDGAR and AI‑generated highlights, this page helps investors and analysts quickly understand what ACM Research reports to regulators about its semiconductor equipment and advanced packaging business.
ACM Research Inc — The Vanguard Group filed a Schedule 13G/A (Amendment No. 3) reporting 0 shares and 0% beneficial ownership of ACM Research Inc common stock as disclosed in the amendment.
The filing explains that on January 12, 2026 Vanguard completed an internal realignment and certain subsidiaries or business divisions will report beneficial ownership separately on a disaggregated basis in reliance on SEC Release No. 34-39538. The submission is signed by Vanguard's Head of Global Fund Administration on March 26, 2026.
ACM Research, Inc. reports that its Shanghai subsidiary, ACM Research (Shanghai), Inc., has proposed a 2025 cash dividend of RMB 6.233 per 10 shares (inclusive of tax), subject to approval at its 2026 Annual General Meeting of Shareholders.
Based on 480,164,789 shares outstanding as of December 31, 2025 and after deducting 443,400 repurchased shares, ACM Shanghai plans a total cash dividend of RMB 299,010,341.76, equal to 21.42% of 2025 net profit attributable to shareholders. Including RMB 50,012,340.46 of share repurchases, total cash returns for 2025 would be RMB 349,022,682.22, or 25.00% of net profit. ACM Shanghai notes it continues to invest heavily in R&D and that its proposed payout will not materially affect operating cash flows.
ACM Research, Inc. furnished an English translation of an investor relations call held by its majority-owned subsidiary ACM Research (Shanghai), Inc. on March 10, 2026. Management discussed 2025 performance, technology roadmap, overseas expansion and detailed financial targets for 2026.
ACM Shanghai expects 2026 revenue between RMB 8.2 billion and RMB 8.8 billion, targeting a gross margin of 42% to 48% and R&D spending at 14% to 19% of revenue. The company highlighted growth opportunities in panel-level packaging for AI chips, front-end track tools and PECVD systems.
Management emphasized localization of components, noting full domestic sourcing of non-standard parts and progress on key standard components. They stated that 2025 asset impairment provisions and recent component price movements are not expected to have a material adverse effect on ongoing operations, while reaffirming a constructive multi-year semiconductor industry outlook.
ACM Research, Inc. officer Mark McKechnie exercised stock options and sold the resulting shares. He exercised options covering 98,551 shares of Class A common stock at exercise prices of $13.89 and $19.49 per share, then sold 98,551 shares in open-market transactions at weighted average prices in the mid-$40s. The sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 27, 2025, indicating the transactions were scheduled in advance rather than timed discretionarily.
ACM Research insider David H. Wang, a director, officer and more than 10% owner, exercised stock options and sold shares of Class A Common Stock. On March 11–12, 2026, he exercised options for a total of 110,000 shares at an exercise price of $1.00 per share.
Over the same two days, Wang executed open-market sales totaling 110,000 shares at weighted average prices ranging from the mid‑$44 to high‑$48 range, under a pre-arranged Rule 10b5‑1 trading plan adopted on November 29, 2024. After these transactions, he held 802,708 shares directly, plus additional indirect holdings through family members and family trusts.
ACM Research, Inc. director Tracy Liu reported an exercise-and-sell transaction involving company stock. On March 10–11, 2026, Liu exercised stock options to acquire a total of 60,000 shares of Class A Common Stock at an exercise price of $1.00 per share. The same 60,000 shares were then sold in open-market transactions at weighted average prices within ranges from $46.67 to $48.50, under a pre-arranged Rule 10b5-1 trading plan adopted on December 4, 2025. After these transactions, Liu directly held 110,772 shares of Class A Common Stock.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice for the proposed sale of 50,000 shares of Common Stock related to a stock option exercise dated 03/12/2026. The filing records the method as cash and lists the transaction in connection with securities traded on NASDAQ.
The notice also discloses a prior sale of 60,000 shares on 03/11/2026 with an aggregate reported value of $2,875,386.00.
ACM Research, Inc. director Haiping Dun exercised stock options for 5,000 shares of Class A Common Stock at $5.60 per share, then sold 5,000 shares in open-market transactions around $43–$44 per share. These sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on August 13, 2025. Following the trades, Dun reported no direct Class A Common Stock holdings, while continuing to hold 55,000 stock options and indirect ownership of 100,000 and 755,090 Class A shares through family trusts.
ACMR affiliate reported a proposed sale of 15,000 common shares under a Form 144. The filing lists the planned sale as a stock option exercise to be effected on 03/11/2026 and indicates cash as the method. The excerpt also shows 45,000 common shares sold on 03/10/2026 for 2,132,248.50 as a recent disposition.